PPA
DNTH icon

Parametric Portfolio Associates’s Dianthus Therapeutics DNTH Stock Holding History

Parametric Portfolio Associates’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$61K Buy
+1,322
New +$72.2K ﹤0.01% 3615
2021
Q4 		– Sell
-950
Closed -$111K – 3654
2021
Q3 		$111K Buy
+950
New +$111K ﹤0.01% 3522

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Parametric Portfolio Associates's DNTH Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Dianthus Therapeutics (DNTH) in Q1 2022: 1,322 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #3615 among its holdings. This is a return to the name: Parametric Portfolio Associates previously reported a position in DNTH as recently as Q3 2021.

Parametric Portfolio Associates first reported a position in DNTH in Q3 2021 and has held it in 2 quarters since. The position peaked at $111K in Q3 2021. 93 funds tracked by Wall St. Rank hold DNTH as of Q1 2022.

  • Parametric Portfolio Associates held 1,322 shares of Dianthus Therapeutics worth $61K as of Q1 2022.
  • Dianthus Therapeutics was a new Parametric Portfolio Associates position in Q1 2022.
  • Dianthus Therapeutics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3615 holding.
  • Parametric Portfolio Associates first reported a position in Dianthus Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • Parametric Portfolio Associates's Dianthus Therapeutics position peaked at $111K in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.